Developing new antibiotics to combat drug-resistant bacteria
Tethered aza-Wacker Technology for Complex Antibiotic Assembly
This study is working on new types of antibiotics to help fight infections caused by bacteria that don't respond to regular treatments, so patients can have safer and more effective options when they get sick.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project ID | NIH-10880715 on NIH RePORTER |
What this research studies
This research focuses on creating new antibacterial agents to address the growing problem of antibiotic resistance. It aims to develop innovative chemical methods for synthesizing complex antibiotics that can effectively target resistant bacterial strains. By exploring new reactions and methodologies, the project seeks to produce antibiotics with unique mechanisms of action, potentially leading to safer and more effective treatments for bacterial infections. Patients may benefit from these advancements through improved treatment options that reduce the risk of toxicity associated with current antibiotics.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections that are resistant to standard antibiotic treatments.
Not a fit: Patients with infections that are easily treatable with existing antibiotics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with new, safer antibiotics to treat infections caused by drug-resistant bacteria.
How similar studies have performed: Previous research has shown promise in developing new antibiotics using innovative chemical synthesis methods, indicating potential for success in this approach.
Where this research is happening
Lawrence, United States
- University of Kansas Lawrence — Lawrence, United States (Active)
Researchers
- Principal investigator: Sathyamoorthi, Shyam — University of Kansas Lawrence
- Study coordinator: Sathyamoorthi, Shyam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.